Novel Cdk2/Cdk9 Inhibitor Fadraciclib Targets Cell Survival and Dna Damage Pathways and Synergizes with Encorafenib in Human Colorectal Cancer Cells with Braf(V600E)

AuthID
P-019-V60
4
Author(s)
Mohiuddin, M
·
Póvoa, V
·
Sinicrope, FA
Document Type
Article
Year published
2025
Published
in ONCOGENESIS, ISSN: 2157-9024
Volume: 14, Issue: 1
Indexing
Publication Identifiers
Pubmed: 40769976
Scopus: 2-s2.0-105012717084
Wos: WOS:001545149400001
Source Identifiers
ISSN: 2157-9024
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.